InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Morrow Phuong Khanh. Officer active across 2 companies, notably CRISPR Therapeutics AG. In total, 3 reports have been logged. Activity tracked since 7 February 2025. The latest transaction was disclosed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations